Next Article in Journal
Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric Cancer
Next Article in Special Issue
Resveratrol-Loaded Polymeric Nanoparticles: The Effects of D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) on Physicochemical and Biological Properties against Breast Cancer In Vitro and In Vivo
Previous Article in Journal
Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer
 
 
Article
Peer-Review Record

Myo-Inositol Reverses TGF-β1-Induced EMT in MCF-10A Non-Tumorigenic Breast Cells

Cancers 2023, 15(8), 2317; https://doi.org/10.3390/cancers15082317
by Noemi Monti 1,2,*, Simona Dinicola 2, Alessandro Querqui 1,2, Gianmarco Fabrizi 2, Valeria Fedeli 1,2, Luisa Gesualdi 3, Angela Catizone 3, Vittorio Unfer 2,4,5 and Mariano Bizzarri 1,2,4,*
Reviewer 1:
Reviewer 2:
Cancers 2023, 15(8), 2317; https://doi.org/10.3390/cancers15082317
Submission received: 27 March 2023 / Revised: 12 April 2023 / Accepted: 13 April 2023 / Published: 15 April 2023
(This article belongs to the Special Issue Advances in Breast Cancer: From Pathogenesis to Therapy)

Round 1

Reviewer 1 Report

This is an extremely important study providing evidence for normalization of pre-cancerous or early tumor environment by a nont-toxic all natural nutritional supplement via EMT reversal with documented critical role of E-cadherin. This approach - non-toxic treatment of cancer via normalization of tissue microenvironment has potential to revolutionize cancer treatment. 

 

Minor revision:

Fig. 1 would benefit from contrast enhancement.

 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

 

cancers-2338986-peer-review:  Myo-inositol reverses TGF-b1-induced EMT in MCF10A non-tumorigenic breast cells.

 

This is a very strong paper addressing a comprehensive set of studies examining the capability of myo-inositol to reverse the Epithelial-Mesenchyme Transition (EMT) induced and sustained by TGF-b1 during inflammatory and cancer initiating processes.  The ntroductory literature review is appropriate for understanding the logic of the series of experiments conducted by the authors.  The complex Methodology and Results sections are clear (but see comments below), and the Discussion appropriately puts the data into cellular and physiological context based on appropriate referencing to the relevant published literature.

 

The choice of assays allowed for a comprehensive demonstration of the effects of TGF-b1, alone, and the almost total reversal of those effects when myo-inositol is added, to the cellular and subcellular integrity of the MCF10A cells.  The results potentially have both basic scientific as well as practical (pharmacological) implications.

 

My suggestions for editing are all meant to address clarity in the presentation of the data, mainly in the figures, as well as a couple of suggested edits in the Discussion..

 

Methods:

·      Line 195.  Please remove the symbols attached to various levels of significance.  Instead, these symbols and their interpretations should reside in figure legends.  The sentence should read, “… standard error of the mean, and p values of <.05 were considered statistically significant.”

 

Results:

·      All figures require appropriate legends.  While the results are described well in the text of the manuscript, legends make the reading of the figures much easier for the reader.  And, as suggested above, this is where the information about comparisons and statistical significance should be placed.

 

Discussion:

·      Line 453.   Reword to something less folksy, such as, ‘It remains to be determined whether a more prolonged period of treatment would have resulted in a more complete reversion.’

·      Lines 494-496.  This quote, from an unidentified source, has good content but is odd in format.  At least preface the quote with, ‘As Solomon and colleagues have noted, ….’

End notes:

·      Lines 499 on:  All of the information in these several sections needs to be provided.

 

Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop